Podcast

Speaking of Urology podcast: Dr. Angela Smith discusses Jelmyto for low-grade UTUC

In this episode, Angela B. Smith, MD, MS, of UNC Lineberger Comprehensive Cancer Center, discusses the recent FDA approval of Jelmyto, which is the first therapy for the treatment of low-grade upper tract urothelial cancer.

Related Videos
Interpreting ART toxicity and tolerability for bladder cancer, with Vedang Murthy, MD
© 2024 MJH Life Sciences

All rights reserved.